These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 4121179

  • 1. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG, May J, Rogers JH, Storey BG, Katran DC, Duggin GG, Johnson JR, Stewart JH.
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM, Mendes NF, Ramos OL, Sabbaga E.
    Rev Bras Pesqui Med Biol; 1972 Mar; 5(5):251-8. PubMed ID: 4573042
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quadruple therapy for cadaver renal transplantation.
    Deierhoi MH, Sollinger HW, Kalayoglu M, Belzer FO.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1917-9. PubMed ID: 3274452
    [No Abstract] [Full Text] [Related]

  • 6. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN.
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract] [Full Text] [Related]

  • 7. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM, Callender CO, Dunston GM, Flores J, Walters CS, John D, Yeager C, Bond O, Thompson C, Gear JC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract] [Full Text] [Related]

  • 8. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
    Dormont J, Kreis H, Leski M, Bach JF, Crosnier J.
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946
    [No Abstract] [Full Text] [Related]

  • 9. Infection in kidney transplantation.
    Burgos-Calderon R, Pankey GA, Figueroa JE.
    Surgery; 1971 Sep; 70(3):334-40. PubMed ID: 4105515
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of antithymocyte globulin in human heart transplantation.
    Griepp RB, Stinson EB, Dong E, Phillips RC, Morrell RM, Shumway NE.
    Circulation; 1972 May; 45(5 Suppl 1):I147-53. PubMed ID: 4554349
    [No Abstract] [Full Text] [Related]

  • 12. Clinical transplantation--an overview.
    Kountz SL.
    Transplant Proc; 1973 Mar; 5(1):59-65. PubMed ID: 4572118
    [No Abstract] [Full Text] [Related]

  • 13. Preliminary studies on antithymocyte globulin.
    Orlowski T, Skopińska E, Kossowska-Paul B, Wasik M, Wojtulewicz-Kurkus J, Klopotowska E, Tupalska B, Filipowicz Z.
    Pol Med J; 1971 Mar; 10(2):400-7. PubMed ID: 4997629
    [No Abstract] [Full Text] [Related]

  • 14. Alternate-day steroids in children after renal transplantation.
    Potter DE, Holliday MA, Wilson CJ, Salvatierra O, Belzer FO.
    Transplant Proc; 1975 Mar; 7(1):79-82. PubMed ID: 47201
    [No Abstract] [Full Text] [Related]

  • 15. The adjunctive value of equine antithymocyte membrane globulin in a randomized study of patients undergoing cadaveric renal transplantation.
    Diethelm AG, Blackstone E, Whelchel JD, Pass RF, Chambers L, Phillips SJ, Thiry C.
    Transplant Proc; 1979 Mar; 11(1):27-30. PubMed ID: 377644
    [No Abstract] [Full Text] [Related]

  • 16. ULF ballistocardiography in human cardiac transplantation.
    Shakespeare T, Reitan JA, Smith NT, Stinson EB, Shumway NE.
    Bibl Cardiol; 1971 Mar; ():Suppl 27:1-9. PubMed ID: 4935282
    [No Abstract] [Full Text] [Related]

  • 17. Clinical aspects of allograft rejection.
    Williams GM.
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract] [Full Text] [Related]

  • 18. Hyperacute and acute fulminating rejection of human renal allografts.
    Williams GM, Sterioff S, Bias W.
    Transplant Proc; 1972 Dec; 4(4):665-7. PubMed ID: 4566816
    [No Abstract] [Full Text] [Related]

  • 19. Cox regression analysis of outcome risk factors in 519 renal allograft recipients.
    Canafax DM, Savik SK, Draxler CA, Le CT, Ascher NL, Payne WD, Sutherland DE, Migliori RJ, Simmons RL, Najarian JS.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1947-8. PubMed ID: 3274455
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.